JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
[Advanced]

The most recent version of this article was published on 1 January 2008

J Clin Pathol. Published Online First: 5 April 2007. doi:10.1136/jcp.2006.044735
Copyright © 2007 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
jcp.2006.044735v1
61/1/49    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by qi, T.
Right arrow Articles by Zhu, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by qi, T.
Right arrow Articles by Zhu, B.

Molecular Pathology

Comparative proteomic analysis for the detection of biomarkers in pancreatic ductal adenocarcinomas

Tonggang qi 1, Jinxiang Han 2*, Yazhou Cui 2, Meijuan Zong 2, Xiaoyong Liu 2 and Bo Zhu 2

1 The Second Hospital of Shandong University, China
2 Shandong Medicinal Biotechnology Center, Shandong Academy of Medical Sciences, China

* To whom correspondence should be addressed. E-mail: han98888{at}yahoo.com.cn.

Accepted 10 January 2007


*   Abstract

Aims: To search for novel potential protein biomarkers for the early detection and better intervention of PDAC.

Methods: Eight pairs of matched PDAC and non-cancerous pancreas tissues were profiled with 2-DE, differentially expressed proteins were identified by MS. Expression patterns of TBX4 and HSP60 were studied with immunohistochemistry using tissue microarrays.

Results: A total of 48 differentially expressed proteins were identified, of them, 30 proteins were novel potential biomarkers. Immunohistochemistry showed that TBX4 expression could be seen in both centroacinar cells and small ducts in normal pancreas and tumor cells in 5/5(100%) well differentiated, 35/38(92.1%) moderately differentiated, and 11/18(61.1%) poorly differentiated PDAC tissues with different staining intensity, however, in normal acinar cells and tumor cells in the other 3/38(7.9%) moderately differentiated and 7/18(38.9%) poorly differentiated PDAC tissues, there was no visible TBX4 expression, the expression difference of TBX4 between moderately differentiated and poorly differentiated PDAC tissues was found to be statistically significant (P <0.01). In addition, there was obvious morphology difference between TBX4 negatively stained and positively stained tumor cells which suggest different celluar origins. Strong expression of HSP60 could be seen in both acinar cells and small ducts in normal pancreas tissues and tumor cells in PDAC tissues except for islets and tumor stoma and no correlation was found between HSP60 expression and differentiation of PDAC tissues.

Conclusions: We identified 30 novel potential biomarkers differentially expressed in PDAC tissues and found that TBX4 may be a differentiation related protein, its prognostic value for PDAC deserve further study.

Key Words: HSP60, TBX4, biomarkers, pancreatic ductal adenocarcinoma, proteomics







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.